ATMP Catalyst
ATMP Catalyst supports early-stage projects and startups in advanced therapies through a structured three-year program. It offers expert mentoring and training, regulatory guidance, access to equipped lab spaces, and connections with key industry players. By linking participants with investors, hospitals, and CDMOs, it accelerates their path to clinical trials and market entry.
Hybrid (online & onsite)
English
Leitat & Parc Científic de Barcelona
FREE: Mentoring, training, regulatory support, and facilitation of connections with key partners. SUBSIDIZED: Access to laboratories.
Advancing science.
Empowering startups.
Transforming healthcare.
Why an advanced therapies accelerator?
Advanced therapies represent the future of medicine, offering more specific, customizable, and effective treatments. To strengthen the health innovation ecosystem, foster the creation of new companies, and support their growth with the goal of positioning Catalonia as a benchmark in the development of advanced therapies, Biocat is launching ATMP Catalyst, the first acceleration program for advanced therapies in Catalonia. The goal is to enhance the existing advanced therapies ecosystem in the BioRegion, increasing both the quality and quantity of projects and companies dedicated to these innovative therapies.
The most complete accelerator of advanced therapies
The projects and/or startups that become part of ATMP Catalyst will have:
Subsidized workspaces
Participants have the opportunity to access spaces at Leitat and the Barcelona Scientific Park (PCB-UB), tailored to the needs of the projects.
Mentoring
Leading professionals in the advanced therapies sector, with experience in key areas such as regulation, intellectual property, market access, business models, and clinical development
Training
25 hours of theoretical training complemented with two practical case studies and the opportunity to have individualized sessions with experts from the ecosystem.
Networking and visibility
Connections with investors, public-private collaboration opportunities, and international projection through Biocat's network and initiatives.
Phases and Training Program
Objectives:
- Formulation of the technological concept.
- Development of initial prototypes.
- Initial in vitro preclinical studies.
- Evaluation of technical feasibility and collection of scientific documentation.
Training Program:
- Regulatory roadmap
- Market acces
- Intellectual property
- Financing
6 months to move from TRL 2-3 to TRL 3-4.
Objectives:
- Validation of the experimental proof of concept.
- Development of advanced prototypes.
- Validation of the mechanism of action.
- Preliminary safety assessment.
- Preparation of documentation and scientific reports.
Training Program:
- Identification of specific regulatory requirements
- Market feasibility study and identification of potential clients
- Legal protection through patents or copyrights
- Seeking new funding sources to advance the research
1 year – TRL 3-4
Objectives:
- Technological validation in laboratories.
- Determination of the regulatory and scaling strategy.
- Preparation of clinical trial design.
- Preliminary regulatory interactions.
Training Program:
- Regulatory compliance to advance toward clinical trials.
- Establishment of market entry strategies.
- Expansion of intellectual property protection.
- Securing funding for next development phases.
1 year – TRL 4-5
Partners
An initiative of
Co-organized by
With the collaboration of
Need more information?
Contact us and we’ll help you find the solution you need.
